Fevipiprant-13CD3 is the labeled version of F321755. Fevipiprant is used in the oral treatment of asthma and has been successful in targeting severe eosinophilic asthma. Fevipiprant is a novel oral prostaglandin D2 receptor 2 (DP2, known as CRTh2) antagonist and currently in development for the treatment of severe asthma and atopic dermatitis. Molecular Formula: C1813CH14D3F3N2O4S Molecular Weight: 430.42 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
430.42
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
